BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fiorentini G, Aliberti C, Sarti D, Coschiera P, Tilli M, Mulazzani L, Giordani P, Graziano F, Gonzalez AM, Marcos RG, Mugnoz FG, Cantore M, Ricci S, Catalano V, Mambrini A. Locoregional therapy and systemic cetuximab to treat colorectal liver metastases. World J Gastrointest Oncol 2015; 7(6): 47-54 [PMID: 26090075 DOI: 10.4251/wjgo.v7.i6.47]
URL: https://www.wjgnet.com/1948-5204/full/v7/i6/47.htm
Number Citing Articles
1
Shamar Young, Donna D’Souza, Siobhan Flanagan, Jafar Golzarian. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic DiseaseCardioVascular and Interventional Radiology 2017; 40(4): 496 doi: 10.1007/s00270-016-1537-5
2
Ron C. Gaba, R. Peter Lokken, Ryan M. Hickey, Andrew J. Lipnik, Robert J. Lewandowski, Riad Salem, Daniel B. Brown, T. Gregory Walker, James E. Silberzweig, Mark Otto Baerlocher, Ana Maria Echenique, Mehran Midia, Jason W. Mitchell, Siddharth A. Padia, Suvranu Ganguli, Thomas J. Ward, Jeffrey L. Weinstein, Boris Nikolic, Sean R. Dariushnia. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic MalignancyJournal of Vascular and Interventional Radiology 2017; 28(9): 1210 doi: 10.1016/j.jvir.2017.04.025
3
Giammaria Fiorentini, Donatella Sarti, Roberto Nani, Camillo Aliberti, Caterina Fiorentini, Stefano Guadagni. Updates of colorectal cancer liver metastases therapy: review on DEBIRIHepatic Oncology 2020; 7(1) doi: 10.2217/hep-2019-0010
4
Young Hong, Robert C. G. Martin. Personalizing Locoregional Therapy for Patients with Metastatic Colorectal CancerCurrent Colorectal Cancer Reports 2017; 13(2): 126 doi: 10.1007/s11888-017-0356-7
5
Jeffrey Chakedis, Malcolm H. Squires, Eliza W. Beal, Tasha Hughes, Heather Lewis, Anghela Paredes, Mazen Al-Mansour, Steven Sun, Jordan M. Cloyd, Timothy M. Pawlik. Update on current problems in colorectal liver metastasisCurrent Problems in Surgery 2017; 54(11): 554 doi: 10.1067/j.cpsurg.2017.10.002
6
Arash Fereydooni, Brian Letzen, Mansur A. Ghani, Milena A. Miszczuk, Steffen Huber, Julius Chapiro, Todd Schlachter, Jean-Francois Geschwind, Christos Georgiades. Irinotecan-Eluting 75–150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I StudyJournal of Vascular and Interventional Radiology 2018; 29(12): 1646 doi: 10.1016/j.jvir.2018.08.010
7
Marcin Szemitko, Elzbieta Golubinska-Szemitko, Jerzy Sienko, Aleksander Falkowski, Ireneusz Wiernicki. Efficacy of Liver Chemoembolization after Prior Cetuximab Monotherapy in Patients with Metastatic Colorectal CancerCancers 2023; 15(2): 541 doi: 10.3390/cancers15020541
8
A. A. Polikarpov, P. G. Tarazov, T. I. Kagacheva, V. V. Borovik, A. V. Kozlov, D. A. Granov. Intraarterial chemotherapy in treatment of unresectable colorectal liver metastases refractory to systemic chemotherapyAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(4): 37 doi: 10.16931/1995-5464.2019437-44
9
Giammaria Fiorentini, Donatella Sarti, Michele Nardella, Riccardo Inchingolo, Massimiliano Nestola, Alberto Rebonato, Caterina Fiorentini, Camillo Aliberti, Roberto Nani, Stefano Guadagni. Transarterial Chemoembolization Alone or Followed by Bevacizumab for Treatment of Colorectal Liver MetastasesHepatic Oncology 2022; 9(1) doi: 10.2217/hep-2020-0031
10
Mark McGregor, Gonzalo Tapia Rico, Amanda Townsend, Tim Price. Cancer Management and Therapy2018;  doi: 10.5772/intechopen.73014
11
Joseph J. Zhao, Eelin Tan, Rehena Sultana, Nicholas L. Syn, Kun Da Zhuang, Sum Leong, David W.M. Tai, Chow Wei Too. Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: A Meta-AnalysisJournal of Vascular and Interventional Radiology 2021; 32(11): 1536 doi: 10.1016/j.jvir.2021.05.032
12
Vincenzo Di Noia, Michele Basso, Valentina Marsico, Eleonora Cerchiaro, Sabrina Rossi, Ettore D’Argento, Antonia Strippoli, Giovanni Schinzari, Roberto Iezzi, Alessandra Cassano, Carlo Barone. DEBIRI Plus Capecitabine: A Treatment Option for Refractory Liver-Dominant Metastases from Colorectal CancerFuture Oncology 2019; 15(20): 2349 doi: 10.2217/fon-2017-0025
13
Olaguoke Akinwande, Meaghan Dendy, Johannes M. Ludwig, Hyun S. Kim. Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic reviewSurgical Oncology 2017; 26(3): 268 doi: 10.1016/j.suronc.2017.05.003
14
Orkun Sarioglu, Ahmet Ergin Capar, Umit Belet. Colon Polyps and Colorectal Cancer2021; : 629 doi: 10.1007/978-3-030-57273-0_31
15
Thomas Helmberger, Pierleone Lucatelli, Philippe L. Pereira, Aleksandar Gjoreski, Ivona Jovanoska, Zoltan Bansaghi, Stavros Spiliopoulos, Francesca Carchesio, Dirk Arnold, Andreas Baierl, Bleranda Zeka, Nathalie C. Kaufmann, Julien Taieb, Roberto Iezzi. Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 PatientsJournal of Clinical Medicine 2022; 11(20): 6178 doi: 10.3390/jcm11206178
16
Diamantis I. Tsilimigras, Ioannis Ntanasis-Stathopoulos, Fabio Bagante, Demetrios Moris, Jordan Cloyd, Eleftherios Spartalis, Timothy M. Pawlik. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidenceSurgical Oncology 2018; 27(2): 280 doi: 10.1016/j.suronc.2018.05.012
17
Giammaria Fiorentini, Donatella Sarti, Camillo Aliberti, Riccardo Carandina, Andrea Mambrini, Stefano Guadagni. Multidisciplinary approach of colorectal cancer liver metastasesWorld Journal of Clinical Oncology 2017; 8(3): 190-202 doi: 10.5306/wjco.v8.i3.190